The PSIP project for Adverse Drug Events prevention

被引:1
|
作者
Bernonville, S. [1 ]
Guillot, B. [2 ]
Pedersen, H. G. [3 ]
Koutkias, V. [4 ]
Beuscart, R. [1 ]
机构
[1] CHU Lille, UDSL EA 2694, F-59000 Lille, France
[2] MEDASYS, F-91193 Gif Sur Yvette, France
[3] IBM Denmark ApS, IBM Global Business Serv, Healthcare, DK-2800 Lyngby, Denmark
[4] Aristotle Univ Thessaloniki, Sch Med, Lab Med Informat, Thessaloniki 54124, Greece
关键词
D O I
10.1016/j.irbm.2013.09.001
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The objective of Clinical Decision Support (CDSS) systems coupled with Computerised Physician Order Entry (CPOE) systems is to improve patient safety. However, there are still issues to be considered to improve the quality of CDSS, especially the difficulty to share the knowledge developed by institutions or healthcare organisations and to exploit it for other medical application. The aim of the Patient Safety through Intelligent Procedures (PSIP) project is to propose innovative tools to generate and provide relevant knowledge to healthcare professionals and patients for Adverse Drug Events (ADE) prevention. The particularity of the PSIP project is to consider the share of knowledge and the interoperability of medical applications via the elaboration of a Global Knowledge Platform (GKP). In this paper, we present the different components of the PSIP GKP and we show its implementation through three medical applications: a web application, an Electronic Health Record (EHR) and a CPOE. (C) 2013 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:263 / 266
页数:4
相关论文
共 50 条
  • [1] Prevention of adverse drug events
    不详
    [J]. JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2001, 8 (04) : 256 - 256
  • [2] Prevention of adverse drug events
    Farmer, B.
    [J]. CLINICAL TOXICOLOGY, 2014, 52 (06) : 573 - 578
  • [3] INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION
    BATES, DW
    CULLEN, DJ
    LAIRD, N
    PETERSEN, LA
    SMALL, SD
    SERVI, D
    LAFFEL, G
    SWEITZER, BJ
    SHEA, BF
    HALLISEY, R
    VANDERVLIET, M
    NEMESKAL, R
    LEAPE, LL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01): : 29 - 34
  • [4] The PSIP Approach to Account for Human Factors in Adverse Drug Events: Preliminary Field Studies
    Riccioli, Costanza
    Leroy, Nicolas
    Pelayo, Sylvia
    [J]. DETECTION AND PREVENTION OF ADVERSE DRUG EVENTS: INFORMATION TECHNOLOGIES AND HUMAN FACTORS, 2009, 148 : 197 - 205
  • [5] Financial impact of adverse drug events prevention
    Plichon, Philippe
    Bousquet, Chloe
    Pourrat, Xavier
    Delerue, Dominique
    Remerand, Francis
    Rosset, Philippe
    Favard, Luc
    Grassin, Jacqueline
    Bourgoin, Helene
    [J]. PHARMACY WORLD & SCIENCE, 2009, 31 (02): : 248 - 249
  • [6] A Knowledge Engineering Framework towards Clinical Support for Adverse Drug Event Prevention: The PSIP Approach
    Koutkias, Vassilis
    Stalidis, George
    Chouvarda, Ioanna
    Lazou, Katerina
    Kilintzis, Vassilis
    Maglaveras, Nicos
    [J]. DETECTION AND PREVENTION OF ADVERSE DRUG EVENTS: INFORMATION TECHNOLOGIES AND HUMAN FACTORS, 2009, 148 : 131 - 141
  • [7] The Rresearch on Adverse Drug Events and Reports (RADAR) project
    Bennett, CL
    Nebeker, JR
    Lyons, EA
    Samore, MH
    Feldman, MD
    McKoy, JM
    Carson, KR
    Belknap, SM
    Trifilio, SM
    Schumock, GT
    Yarnold, PR
    Davidson, CJ
    Evens, AM
    Kuzel, TM
    Parada, JP
    Cournoyer, D
    West, DP
    Sartor, O
    Tallman, MS
    Raisch, DW
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (17): : 2131 - 2140
  • [8] A Prescription for Prescribers: Prevention of Adverse Drug Events in the Elderly
    Nirmalasari, O.
    Amjad, H.
    Christmas, C.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S198 - S198
  • [9] Toward Automatic Detection and Prevention of Adverse Drug Events
    Leroy, Nicolas
    Chazard, Emmanuel
    Beuscart, Regis
    Beuscart-Zephir, Marie Catherine
    [J]. ADVANCES IN INFORMATION TECHNOLOGY AND COMMUNICATION IN HEALTH, 2009, 143 : 30 - +
  • [10] Pharmacists role in prevention of adverse drug events in UAE
    Abou Sheishae, A. A.
    Saber, M. M.
    Attia, F. M.
    Al Qaydi, G. A.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 900 - 900